Navigation Links
Risk Of Birth Defects Increased Due To Anti-Depressant Medication

A warning has been issued to all physicians, more specifically to pregnant women against the prescription and consumption of Paxil, given for treatment of depression due to the risk of increased congenital// heart defects in newborns.

The notice has been issued by the Food and Drug Administration (FDA) and is based on early findings of two studies, which had demonstrated that women who took Paxil during the first trimester had a two fold increased risk of giving rise to babies with congenital heart defects compared to other pregnant women. The risk of birth defect was significantly higher compared to pregnant women who took other forms of anti-depressant medication.

In the studies cited by the FDA, the risk of congenital heart defects is about 1 percent overall, which rose to 1.5 to 2 percent in infants born to women taking Paxil. Following the notification, the drug has been placed in the second highest category for risk of birth defects. It is generally advisable to avoid all drugs during pregnancy. However in case use of an anti-depressant medication is very necessary, it is safer to use other medicines as a substitute after a careful consultation with the physician.

The physicians have also been alerted regarding the adverse effects arising out of sudden withdrawal of Paxil. Though it was known that selective serotonin reuptake inhibitors (SSRIs) could harm fetuses, the magnitude of the risk has not been studied previously. The recent report by the FDA and GlaxoSmithKline (manufacturer of Paxil) is the only strong evidence that it can result in birth defects.

Approximately 20% of all pregnant women are estimated to suffer from some form of depression. This creates confusion about the initiation and continuation of anti-depressant medication in pregnancy. The increased tendency of pregnant women to display irritable behaviour, tremors and seizures following childbirth has posed additional concerns regarding mother’s healt h.

Ever since the time of approval in 1993, the drug has been taken by over millions worldwide. Women of childbearing age (18-45 yrs) constitute 25% of the total number of Paxil users. Although several studies have demonstrated the effectiveness of Paxil in the treatment of depression, anxiety disorder and other psychiatric disorders in adults, the data available on the safe use of Paxil is very limited.

Keeping in mind the above figure, it is high time that certain guidelines are formulated regarding usage of Paxil. Ultimately, the gold standard rule of benefit Vs risk should dictate the indication for use under all circumstances including pregnancy.
'"/>




Related medicine news :

1. Birth weight key factor in heart diseases
2. FDA Approves Birth Control Skin Patch
3. IVF technique May Increase The Risk Of Birth Defects
4. Smoking Linked To Low Infant Birth Weight
5. Unpredictable Premature Birth
6. New Birth Control Pills increase the stroke risk
7. Epilepsy Drugs Can Enhance Risk of Birth Defects
8. Sex timing has no impact on risk of Birth defects
9. Birth weight may be influenced by genes
10. Dental Procedure Reduces Preterm Births
11. Low Birth Weight infants could have Problems in the Future
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/4/2016)... ... December 03, 2016 , ... The Lymphoma Research Foundation ... research and serving the lymphoma community through a comprehensive series of education programs, ... Event in New York City, with long-time partners The Paul Foundation, on November ...
(Date:12/4/2016)... (PRWEB) , ... December 03, 2016 , ... ... “Fastest growing Entrepreneurial Company in the Dallas area” Tuesday evening at the 26th ... Dallas Hotel, presented by SMU's Cox School’s Caruth Institute for Entrepreneurship. Dallas 100™, ...
(Date:12/4/2016)... ... ... Responsible dental care hinges on regular brushing of the teeth. However, just brushing ... inspired an inventor from Las Vegas, Nev., to design the BRUSH PROPER. , ... bad techniques of brushing the teeth in order to prevent cavities," he said. "Children ...
(Date:12/2/2016)... ... ... On Dec. 2, 2016, CURE® magazine will host the 4th Annual MPN ... Heroes—eight individuals who have made a difference in the field of rare blood cancers ... demonstrating leadership within the MPN community and/or a commitment to individual patients. , This ...
(Date:12/2/2016)... ... December 02, 2016 , ... FlexiSpot, a trusted ... 60-day free trial program for all of the company’s desktop riser products. A ... hassle free experience. , FlexiSpot’s unique desktop risers use an advanced dual gas ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... 2, 2016 Persistence Market Research ... its upcoming report titled, "Global Market Study on Cardiac Pacemaker: ... of -1.4% between 2016 and 2024". The global cardiac pacemaker ... and this is likely to decline to US$ 3923.8 ... cardiac pacemaker market is anticipated to exhibit a declining ...
(Date:12/2/2016)... Dec 2, 2016 Research and Markets has ... Development, Growth and Demand Forecast to 2022" report to their offering. ... , , ... billion in 2015, and it is expected to grow at a CAGR ... expected to witness faster growth during the forecast period, a CAGR of ...
(Date:12/2/2016)... Spain , Dec. 2, 2016 In ... natural sources apart from those derived from C. sativa, ... the Universita` di Napoli Federico II , the ... created the first comprehensive, critical, integrated and unified inventory ... The article focuses on the remarkable chemical and ...
Breaking Medicine Technology: